L-Carnitine in dialysis patients

Seminars in Dialysis

Volumn 14, Issue 3, 2001, Pages 209-217

  Ahmad, Suhail ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARNITINE;

CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; HUMAN; KIDNEY FUNCTION TEST; MALE; METABOLISM; METHODOLOGY; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; SENSITIVITY AND SPECIFICITY; TIME;

BIOLOGICAL MARKERS; CARNITINE; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; PROGNOSIS; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0035345349     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2001.00055.x     Document Type: Article

References (13)

1. Dollery C: Levocarnitine. Ther Drugs 2:L34-L39, 1999
2. Goa KL, Brogden RN: L-carnitine - a preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs 34:1-24, 1987
3. Golper TA, Ahmad S: L-carnitine administration to hemodialysis patients: has its time come? Semin Dial 5:94-98, 1992
4. Berard E, Iordache A, Barrillon D, Bayle J: L-carnitine in dialysed patients: the choice of dosage regimen. Int J Clin Pharmacol Res 15:127-133, 1995
5. Wanner C, Förstner-Wanner S, Rössle C, Fürst P, Schollmeyer P, Hörl WH: Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation. Kidney Int 32(suppl 22):S132-S135, 1987
6. Wanner C, Hörl WH: Carnitine abnormalities in patients with renal insufficiency: pathophysiological and therapeutic aspects. Nephron 50:89-102, 1988
7. Kudoh Y, Shoji T, Oimatsu II, Yoshida S, Kikuchi K, Iimura O: The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis. Jpn Circ J 47:1391-1397, 1983
8. Rodriguez-Segade S, de la Pena A, Paz M, Novoa D, Romero R, Arcocha V, Del Rio R: Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency. Ann Clin Biochem 23:671-675, 1986
9. Fürst P, Glöggler A, Rössle C: Carnitine supplementation in uremia. Adv Exp Med Biol 260:69-77, 1989
10. Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 38:904-911, 1990
11. Vacha GM, Giorcelli G, Siliprandi N, Corsi M: Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol. Am J Clin Nutr 38:532-540, 1983
12. Wanner C, Hörl WH: Potential role of carnitine in patients with renal insufficiency. Klin Wochenschr 64:579-586, 1986
13. Van Es A, Henny FC, Kooistra MP, Lobatto S, Scholte HR: Amelioration of cardiac function by L-carnitine in administration in patients on hemodialysis. Contrib Nephrol 98:28-35, 1992